Furthermore, a c-MYC-targeting epigenomic controller, OTX-2002, methylates the MYC IGD region and reduces c-MYC expression in hepatocellular carcinoma (HCC) models. The gene discussed is MYC; the disease is hepatocellular carcinoma.